drugset

drugset / Trial / NCT00547625

Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems

NCT00547625 ↗

Phase 2 Completed 275 enrolled Eli Lilly and Company ICOS Corporation · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

Study to look at safety and effectiveness of different doses of tadalafil on prostate related genital/urinary tract problems.

Timeline

Start: 2004-10
Primary completion: —
Completion: 2005-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Tadalafil	Small molecule	20 mg	Oral

Indications